IRIS

ANGELICO, MARIO

ANGELICO, MARIO  

Dipartimento di Medicina dei sistemi  

Mostra records
Risultati 1 - 20 di 270 (tempo di esecuzione: 0.036 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
15-ott-2003 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation Petrolati, A; Festi, D; De Berardinis, G; Colaiocco Ferrante, L; DI PAOLO, D; Tisone, G; Angelico, M Articolo su rivista
1-gen-2003 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Petrolati, A; Festi, D; De Berardinis, G; Colaiocco Ferrante, L; Di Paolo, D; Tisone, G; Angelico, M Articolo su rivista
1-gen-2008 596 Lenci, I; Tariciotti, L; Baiocchi, L; Manzia, Tm; Toti, L; Craboledda, P; Callea, F; Angelico, M; Tisone, G Articolo su rivista
1-gen-1999 A pilot study on the safety and effectiveness of immunosuppression without prednisone after liver transplantation Tisone, G; Angelico, M; Palmieri, G; Pisani, F; Anselmo, A; Baiocchi, L; Negrini, S; Orlando, G; Vennarecci, G; Casciani, Cu Articolo su rivista
1-set-2014 An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naïve patients with genotype 1 chronic hepatitis C Andriulli, A; Nardi, A; Di Marco, V; Ippolito, A; Gavrila, C; Aghemo, A; DI PAOLO, D; Squadrito, G; Grassi, E; Calvaruso, V; Valvano, M; Brancaccio, G; Craxi, A; Angelico, M; Raimondo, G; Milella, M; Morisco, F; Fattovich, G; Felder, M; Smedile, A; Fasano, M; Gatti, P; Andriulli, N; Tundo, P; Barone, M; Cozzolongo, R; D'Andrea, G; Mazzella, G; Santantonio, T Articolo su rivista
1-gen-2009 A randomized controlled trial of pegylated interferon-alpha2a plus adefovir dipivoxil for hepatitis B e antigen-negative chronic hepatitis B Piccolo, P; Lenci, I; Demelia, L; Bandiera, F; Piras, M; Antonucci, G; Nosotti, L; Mari, T; De Santis, A; Ponti, M; Sorbello, O; Iacomi, F; Angelico, M Articolo su rivista
1-ago-2013 A randomized controlled trial of sequential pegylated interferon-α and telbivudine or vice versa for 48 weeks in hepatitis B e antigen-negative chronic hepatitis B Piccolo, P; Lenci, I; DI PAOLO, D; Demelia, L; Sorbello, O; Nosotti, L; Angelico, M Articolo su rivista
1-gen-2007 A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C Angelico, M; Petrolati, A; Lionetti, R; Lenci, I; Burra, P; Donato, M; Merli, M; Strazzabosco, M; Tisone, G Articolo su rivista
1-gen-2007 A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C. Angelico, M; Petrolati, A; Lionetti, R; Lenci, I; Burra, P; Donato, M; Merli, M; Strazzabosco, M; Tisone, G Articolo su rivista
1-feb-2014 A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial Francioso, S; Almerighi, C; Forte, P; Bandiera, F; Nosotti, L; Lionetti, R; Taliani, G; Piras, M; Ponti, M; Parruti, G; Di Candilo, F; Gentile, S; Piccolo, P; Salso, A; Riccobelli, F; Renzi, S; Longo, M; Montalbano, M; Zaru, S; Biliotti, E; Di Masi, F; Santopaolo, F; Angelico, M Articolo su rivista
1-nov-2013 A survey on mortality from non-variceal upper gastrointestinal bleeding: Is the emergency referral system adequate? Cesaro, P; Kohn, A; Petruziello, L; Angelico, M; Franceschi, F; Gigliozzi, A; Lamazza, A; Tammaro, L; Boschetto, S; Brighi, S; Antoniozzi, A; Baiocchi, L Articolo su rivista
1-gen-2010 Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. Orlando, G; Tariciotti, L; Manzia, Tm; Gravante, G; Sorge, R; Manuelli, M; Pisani, F; Di Cocco, P; Scelzo, C; Burke, G; Soker, S; Baiocchi, L; Lerut, J; Angelico, M; Tisone, G Articolo su rivista
1-ott-1982 Abnormalities in erythrocyte membrane phospholipids in patients with liver cirrhosis Alvaro, D; Angelico, M; Attili, A; De Santis, A; Piéche, U; Capocaccia, L Articolo su rivista
1-gen-2007 Activation of the IGF1 system characterizes cholangiocyte survival during progression of primary biliary cirrhosis Nori, P; Alvaro, D; Floreani, A; Mancino, M; Franchitto, A; Guido, M; Carpino, G; De Santis, A; Angelico, M; Attili, A; Gaudio, E Articolo su rivista
1-gen-2019 Acute Cholangitis with Atypical Clinical Presentation and Imaging Masetti, C; Brega, A; Angelico, M Articolo su rivista
1-feb-1992 Altered insulin receptor processing and membrane lipid composition in erythrocytes of cirrhotic patients Peterson, S; Angelico, M; Masella, R; Foster, K; Gandin, C; Cantafora, A Articolo su rivista
1-gen-2005 Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting Muzi, F; Orlando, G; Ielpo, B; Anselmo, A; Ceraldi, S; De'Liguori Carino, N; Manzia, Tm; D'Andria, D; Tariciotti, L; Angelico, M; Tisone, G Intervento a convegno
1-gen-2005 Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. Muzi, F; Orlando, G; Ielpo, B; Anselmo, A; Sabato Ceraldi, S; de Liguori Carino, N; Manzia, Tm; D'Andria, D; Tariciotti, L; Angelico, M; Tisone, G Articolo su rivista
1-ago-1979 An improved gas-chromatographic method for the determination of sulfated and unsulfated bile acids in serum Cantafora, A; Angelico, M; Attili, A; Ercoli, L; Capocaccia, L Articolo su rivista
1-mar-2013 Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial Sulkowski, M; Poordad, F; Manns, M; Bronowicki, J; Rajender Reddy, K; Harrison, S; Afdhal, N; Sings, H; Pedicone, L; Koury, K; Sniukiene, V; Burroughs, M; Albrecht, J; Brass, C; Jacobson, I; Sprint, 2ti; Angelico, M Articolo su rivista